BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Lifang Hou, Xiao Zhang, Dong Wang, Andrea Baccarelli. Environmental chemical exposures and human epigeneticsInternational Journal of Epidemiology 2012; 41(1): 79 doi: 10.1093/ije/dyr154
2
Ning Zhou, Quankai Gu. Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancerMedicine 2018; 97(12): e0195 doi: 10.1097/MD.0000000000010195
3
Muriel X. G. Draht, Danny Goudkade, Alexander Koch, Heike I. Grabsch, Matty P. Weijenberg, Manon van Engeland, Veerle Melotte, Kim M. Smits. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic reviewClinical Epigenetics 2018; 10(1) doi: 10.1186/s13148-018-0461-8
4
Semra Demokan, Alice Chuang, Yusufhan Suoğlu, Murat Ulusan, Zubeyde Yalnız, Joseph A. Califano, Nejat Dalay. Promoter methylation and loss ofp16INK4agene expression in head and neck cancerHead & Neck 2012; 34(10): 1470 doi: 10.1002/hed.21949
5
EBRU ESIN YORUKER, UFUK MERT, DURSUN BUGRA, SUMER YAMANER, NEJAT DALAY. Promoter and histone methylation and p16INK4A gene expression in colon cancerExperimental and Therapeutic Medicine 2012; 4(5): 865 doi: 10.3892/etm.2012.683
6
Sabita N. Saldanha, Shivani Soni. Epigenetic Advancements in Cancer2016; : 1 doi: 10.1007/978-3-319-24951-3_1
7
Aliaa Atef, Asmaa Bedeer. Expression of α-methyl coenzyme A racemase and p16 in colorectal adenoma and adenocarcinomaEgyptian Journal of Pathology 2016; 36(1): 54 doi: 10.1097/01.XEJ.0000484374.45600.32